Search
for
Sort by
Research 271–300 of 1000+
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- NEW GENERATION OF VACCINE TECHNOLOGIES
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- Human papillomavirus vaccine recombinant quadrivalent
- Safety of Human Papillomavirus Vaccines: A Review
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
- A study of COVID‐19 vaccine (Covishield) induced dermatological adverse effects from India
- Improved Humoral Immunity and Protection against Influenza Virus Infection with a 3d Porous Biomaterial Vaccine
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Decision‐Making Regarding the Administration of Live Vaccines to Patients With a <i>FOXN1</i> Heterozygous Missense Variant
- Alopecia Areata following COVID-19 Vaccine
- Dermatological Adverse Effects of Covid-19 Vaccine among Healthcare Workers: Findings from a Tertiary Care Hospital in Northern India
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- The Chinese State Food and Drug Administration has issued Sinovac Biotech a New Drug Certificate approving its split influenza vaccine
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss
- The relationship between coronavirus disease 2019 (COVID-19) vaccines, abnormal uterine bleeding, and hormonal disorders in women of reproductive age: one-center cross-sectional results
- Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
- Acute Encephalomyelitis Syndromes Associated with H1N1 Influenza Vaccinations; Erythema Multiforme Secondary to H1N1 Vaccine; Cytolytic Hepatitis Possibly Related to Oral Contraceptives; Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Lamotrigine: First Report; Behavioral Disinhibition with Baclofen; Minoxidil-Induced Trichostasis Spinulosa of Terminal Hair; Delayed-Onset Mirtazapine-Related Leukopenia
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
- 40nm, but not 750 or 1,500nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery